P站视频

P站视频. Cancer Facts and Figures 2016. Atlanta, Ga: P站视频; 2016.

P站视频. Cancer Facts and Figures 2017. Atlanta, Ga: P站视频; 2017.

American Joint Committee on Cancer. Corpus Uteri. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 403-409.

Bodurka DC, Gershenson DM. Sarcomas of the female reproductive tract. In: Pollock RE, ed. P站视频 Atlas of Clinical Oncology. Soft Tissue Sarcomas. Hamilton, Ontario: BC Decker; 2002:213-227.

Chan JK, Kawar NM, Shin JY, et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008;99:1210-1215.

Fields A, Jones JG, Thomas GM, Runowicz CD. Gynecologic cancer. In: Lenhard RE Jr, Osteen RT, Gansler T, eds. Clinical Oncology. Atlanta, Ga: P站视频; 2001:455-496.

Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012 Feb;124(2):254-9. Epub 2011 Oct 23.

Hensley ML, Ishill N, Soslow R, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecol Oncol. 2009;112:563-567.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.

Hrzenjak A, Moinfar F, Tavassoli FA, et al. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn. 2005;7:388-395.

Kosary CL. Cancer of the Corpus Uteri. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Lee CH, Mari帽o-Enriquez A, Ou W, et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012 May;36(5):641-53.

Monk BJ, Blessing JA, Street DG, Muller CY, Burke JJ, Hensley ML. A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study. Gynecol Oncol. 2012 Jan;124(1):48-52. Epub 2011 Oct 13.

National Comprehensive Cancer Network. Uterine Neoplasms. V.1.2014. Accessed at www.nccn.org on April 2, 2014.

Nucci MR, Harburger D, Koontz J, Dal Cin P, Sklar J. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol. 2007 Jan;31(1):65-70.

PDQ database. Uterine sarcoma. Bethesda, Md: National Cancer Institute; 10/18/2012. Accessed at http://www.cancer.gov/cancertopics/pdq/treatment/uterinesarcoma/healthprofessional on April 2, 2014.

Rahaman J, Cohen CJ. Gynecologic sarcomas. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E, eds. Cancer Medicine 6. Hamilton, Ontario: BC Decker; 2003:1871-1878.

Ramirez PT, Mundt AJ, Muggia FM. Cancers of the uterine body. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins 2011: 1345-1362.

Reed NS, Mangioni C, Malmstr枚m H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008 Apr;44(6):808-18. Epub 2008 Apr 2. Erratum in: Eur J Cancer. 2008 Jul;44(11):1612.

Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One. 2012;7(11):e50058. doi: 10.1371/journal.pone.0050058. Epub 2012 Nov 26.